PTIX logo

Protagenic Therapeutics (PTIX) Short Term Debt

Annual Short Term Debt

N/A

December 31, 2023


Summary


Performance

PTIX Short Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherPTIXbalance sheetmetrics:

Quarterly Short Term Debt

N/A

September 30, 2024


Summary


Performance

PTIX Quarterly Short Term Debt Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherPTIXbalance sheetmetrics:

Short Term Debt Formula

Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings

PTIX Short Term Debt Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years--
5 y5 years--

PTIX Short Term Debt Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time

Protagenic Therapeutics Short Term Debt History

DateAnnualQuarterly
Sep 2023
-
$419.80 K(+6.5%)
Jun 2023
-
$394.30 K(+6.8%)
Mar 2023
-
$369.10 K(+7.2%)
Dec 2022
$344.20 K(-86.8%)
$344.20 K(+368.3%)
Mar 2016
-
$73.50 K(-88.9%)
Dec 2015
-
$665.00 K(+17.7%)
Sep 2015
-
$565.00 K(+36.1%)
Mar 2015
-
$415.00 K(0.0%)
Dec 2014
-
$415.00 K(+56.6%)
Sep 2014
-
$265.00 K(-93.4%)
Jun 2013
$2.61 M(+40.7%)
-
Sep 2011
-
$4.02 M(+25.5%)
Jun 2011
-
$3.20 M(>+9900.0%)
Sep 2009
-
$0.00(0.0%)
Jun 2009
-
$0.00(-100.0%)
Mar 2009
-
$1.88 M(+1.2%)
Dec 2008
$1.86 M(+1776.8%)
$1.86 M(+3.6%)
Sep 2008
-
$1.79 M(+205.1%)
Mar 2008
-
$588.00 K(+493.9%)
Dec 2007
$99.00 K(-39.3%)
$99.00 K(+11.2%)
Sep 2007
-
$89.00 K(0.0%)
Jun 2007
-
$89.00 K(-86.7%)
Mar 2007
-
$669.00 K(+310.4%)
Jul 2006
-
$163.00 K(-0.1%)
Jul 2006
$163.00 K
-
Apr 2006
-
$163.20 K(+18.1%)
DateAnnualQuarterly
Jan 2006
-
$138.20 K(+45.9%)
Oct 2005
-
$94.70 K(-98.2%)
Jul 2005
$44.00 K(-99.0%)
-
Apr 2003
-
$5.18 M(+24.6%)
Jan 2003
-
$4.16 M(-20.3%)
Oct 2002
-
$5.22 M(+20.7%)
Jul 2002
$4.33 M(-12.3%)
$4.33 M(-13.3%)
Apr 2002
-
$4.99 M(-11.9%)
Jan 2002
-
$5.66 M(+0.7%)
Oct 2001
-
$5.62 M(+14.1%)
Jul 2001
$4.93 M(+20.7%)
$4.93 M(-19.8%)
Apr 2001
-
$6.14 M(+19.2%)
Jan 2001
-
$5.16 M(+18.7%)
Oct 2000
-
$4.34 M(+6.4%)
Jul 2000
$4.08 M(-25.2%)
$4.08 M(-18.3%)
Apr 2000
-
$5.00 M(-10.5%)
Jan 2000
-
$5.58 M(-0.3%)
Oct 1999
-
$5.60 M(+2.6%)
Jul 1999
$5.46 M(+40.9%)
$5.46 M(-4.2%)
Apr 1999
-
$5.70 M(+18.8%)
Jan 1999
-
$4.80 M(+4.3%)
Oct 1998
-
$4.60 M(+18.7%)
Jul 1998
$3.88 M
$3.88 M(-11.9%)
Apr 1998
-
$4.40 M(+29.4%)
Jan 1998
-
$3.40 M(+1033.3%)
Oct 1997
-
$300.00 K

FAQ

  • What is the all time high annual short term debt for Protagenic Therapeutics?
  • What is the all time high quarterly short term debt for Protagenic Therapeutics?

What is the all time high annual short term debt for Protagenic Therapeutics?

Protagenic Therapeutics all-time high annual short term debt is $5.46 M

What is the all time high quarterly short term debt for Protagenic Therapeutics?

Protagenic Therapeutics all-time high quarterly short term debt is $6.14 M